Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19: A meta‐regression analysis
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29718 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von I-Wen Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment, Ritonavir. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan.
- Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan.
- Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan.
ORCID-Profile: I-Wen Chen, Kuo-Chuan Hung
Zitieren
APA
Chen, I. W., Yu, T. S., Lin, C. H., & Hung, K. C. (2024). Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19: A meta‐regression analysis. Journal of Medical Virology. https://doi.org/10.1002/jmv.29718
Vancouver
Chen IW, Yu TS, Lin CH, Hung KC. Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19: A meta‐regression analysis. Journal of Medical Virology. 2024. doi:10.1002/jmv.29718
BibTeX
@article{Chen2024,
author = {Chen, I-Wen and Yu, Ting-Sian and Lin, Chien-Hung and Hung, Kuo-Chuan},
title = {Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19: A meta‐regression analysis},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29718}
}
EUVIMED